##analysisDate=2017-09-08-17-24-51000
##analyzedBy=RingStudy Site F
##exportDate=2017-11-08-11-21-02000
##analysisName=Site F-092-Sample 8-F-SE17-0369-Ring_Study-OCAv3_REPEAT
##workflowName=Oncomine Comprehensive v3 - w2.1 - DNA and Fusions - Single Sample
##sampleNames=SE17-0369_v1:SE17-0369_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=2513
##filterInCount=116
##filteredOutCount=2397
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:40363054	C/C	G	SNV		MYCL	exonic	1								100.00	p.Thr392Ser		930	G=0.0, C=1.0		Present				-	3	NM_001033082.2	c.1175C>G	missense	1.32	1.0	58.0	0.0	Helix-loop-helix DNA-binding domain,Myc amino-terminal region	rs3134614		0.055 (ref)	0.1328	0.0252	0.0963	YES	DNA binding,nucleus,regulation of transcription, DNA-dependent,sequence-specific DNA binding transcription factor activity			0.00001	14083.8	G=0, C=930		G=0/0, C=421/509	1	
chr1:65310489	T/C	T	SNV		JAK1	exonic	1								48.37	p.(=)		1290	T=0.5163, C=0.4837		Present				-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				Protein kinase domain,Protein tyrosine kinase	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	5717.33	T=666, C=624		T=324/342, C=320/304	1	
chr1:65311262	G/A	G	SNV		JAK1	exonic	1								53.36	p.(=)		1756	G=0.4664, A=0.5336		Present				-	15	NM_002227.2	c.2049C>T	synonymous	-1.41				Protein kinase domain,Protein tyrosine kinase	rs2230587		0.196 (ref)	0.1103	0.1892	0.1356	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	9161.94	G=819, A=937		G=431/388, A=532/405	1	
chr1:120458924	G/A	G	SNV		NOTCH2	exonic	1								49.37	p.(=)		1999	G=0.5063, A=0.4937		Present				-	34	NM_024408.3	c.6421C>T	synonymous	1.41				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs3795666		0.029 (ref)	0.0192	0.0154	0.0179	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,anti-apoptosis,bone remodeling,calcium ion binding,cell cycle arrest,cell differentiation,cell fate determination,cell growth,cell surface,cytosol,endoplasmic reticulum lumen,extracellular region,gene expression,hemopoiesis,induction of apoptosis,integral to plasma membrane,multicellular organismal development,negative regulation of cell proliferation,nervous system development,nucleoplasm,nucleus,organ morphogenesis,plasma membrane,positive regulation of Ras protein signal transduction,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,stem cell maintenance,tissue regeneration			0.00001	9203.24	G=1012, A=987		G=464/548, A=450/537	1	
chr1:120468127	C/T	C	SNV		NOTCH2	exonic	1								50.23	p.Val1438Ile		1734	C=0.4977, T=0.5023		Present				-	25	NM_024408.3	c.4312G>A	missense	0.76	0.46	29.0	0.008	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein								Golgi lumen,Notch receptor processing,Notch signaling pathway,anti-apoptosis,bone remodeling,calcium ion binding,cell cycle arrest,cell differentiation,cell fate determination,cell growth,cell surface,cytosol,endoplasmic reticulum lumen,extracellular region,gene expression,hemopoiesis,induction of apoptosis,integral to plasma membrane,multicellular organismal development,negative regulation of cell proliferation,nervous system development,nucleoplasm,nucleus,organ morphogenesis,plasma membrane,positive regulation of Ras protein signal transduction,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,stem cell maintenance,tissue regeneration			0.00001	8176.11	C=863, T=871		C=483/380, T=469/402	1	
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4.E3E4				90				NoCall			2.1176e-07																						0.0					
chr2:29443617	C/G	C	SNV		ALK	exonic	1								53.04	p.(=)		1333	C=0.4696, G=0.5304		Present				-	23	NM_004304.4	c.3600G>C	synonymous	-3.3				MAM domain,Protein kinase domain,Protein tyrosine kinase	rs56247462		0.012	2.0E-4	0.0011	5.0E-4		ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	6840.94	C=626, G=707		C=320/306, G=364/343	6	
chr2:29445458	T/T	G	SNV		ALK	exonic	1								100.00	p.(=)		882	G=0.0, T=1.0		Present				-	21	NM_004304.4	c.3375C>A	synonymous	-1.83				MAM domain,Protein kinase domain,Protein tyrosine kinase	rs3795850		0.395 (ref)	0.2058	0.2519	0.2214	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	13310.1	G=0, T=882		G=0/0, T=493/389	1	
chr2:48010488	G/A	G	SNV		MSH6	exonic	1								41.40	p.Gly39Glu		442	G=0.586, A=0.414		Present				+	1	NM_000179.2	c.116G>A	missense	0.84	0.06	98.0	0.0	MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain	rs1042821		0.193 (ref)	0.1724	0.194	0.1797	YES	ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments		non-pathogenic,probable-non-pathogenic	0.00001	1516.78	G=259, A=183		G=138/121, A=96/87	4	
chr2:48030692	T/A	T	SNV		MSH6	exonic	1								51.63	p.(=)		1228	T=0.4837, A=0.5163		Present				+	5	NM_000179.2	c.3306T>A	synonymous	-2.71				MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain	rs2020910,rs267608092,rs267608093		0.057 (ref)	0.0016	0.01	0.0045	YES	ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments		non-pathogenic	0.00001	5434.91	T=594, A=634		T=300/294, A=250/384	7	
chr2:48030693	T/A	T	SNV		MSH6	exonic	1								10.26	p.Phe1103Ile		1248	T=0.8974, A=0.1026		Present				+	5	NM_000179.2	c.3307T>A	missense	2.1	0.24	21.0	0.387	MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain	rs267608092							ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments			0.00001	322.038	T=1120, A=128		T=550/570, A=18/110	7	
chr3:12458274	C/G	C	SNV		PPARG	exonic	1								47.15	p.(=)		1896	C=0.5285, G=0.4715		Present				+	6	NM_015869.4	c.891C>G	synonymous	-0.66				Ligand-binding domain of nuclear hormone receptor,Zinc finger	rs13306747		0.01				YES	DNA binding,activating transcription factor binding,activation of caspase activity,arachidonic acid binding,cell fate commitment,cell maturation,cellular response to insulin stimulus,cytoplasm,cytosol,drug binding,enzyme binding,epithelial cell differentiation,gene expression,glucose homeostasis,heart development,induction of apoptosis,innate immune response,intracellular receptor mediated signaling pathway,ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity,lipid homeostasis,lipid metabolic process,lipoprotein transport,long-chain fatty acid transport,low-density lipoprotein particle receptor biosynthetic process,metal ion binding,monocyte differentiation,negative regulation of acute inflammatory response,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of cholesterol storage,negative regulation of interferon-gamma-mediated signaling pathway,negative regulation of macrophage derived foam cell differentiation,negative regulation of receptor biosynthetic process,negative regulation of sequestering of triglyceride,negative regulation of telomerase activity,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,organ regeneration,placenta development,positive regulation of fat cell differentiation,positive regulation of fatty acid oxidation,positive regulation of oligodendrocyte differentiation,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,prostaglandin receptor activity,protein binding,receptor activity,regulation of blood pressure,regulation of cholesterol transporter activity,regulation of lipid metabolic process,response to caffeine,response to cold,response to drug,response to estrogen stimulus,response to lipid,response to low-density lipoprotein particle stimulus,response to nutrient,response to organic cyclic compound,response to vitamin A,retinoid X receptor binding,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid hormone receptor activity,transcription regulatory region DNA binding,white fat cell differentiation,zinc ion binding	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,(2S)-2-ETHOXY-3-{4-2-(10H-PHENOXAZIN-10-YL)ETHOXYPHENYL}PROPANOIC ACID,(2S)-2-methoxy-3-{4-2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy-1-benzothiophen-7-yl}propanoic acid,(2S)-3-(1-{2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YLMETHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID,(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid,(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid,(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid,(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid,(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid,(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid,(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,2-(2,4-DICHLOROBENZOYL)AMINO-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID,2-chloro-5-nitro-N-phenylbenzamide,2-{5-3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXYINDOL-1-YL}ETHANOIC ACID,2-{5-3-(7-PROPYL-3-TRIFLUOROMETHYLBENZODISOXAZOL-6-YLOXY)PROPOXYINDOL-1-YL}ETHANOIC ACID,3-(5-methoxy-1H-indol-3-yl)propanoic acid,3-5-(2-nitropent-1-en-1-yl)furan-2-ylbenzoic acid,3-FLUORO-N-1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YLBENZENESULFONAMIDE,3-{5-methoxy-1-(4-methoxyphenyl)sulfonyl-1H-indol-3-yl}propanoic acid,Balsalazide,Bezafibrate,Glipizide,Icosapent,Indomethacin,Mesalazine,Mitiglinide,Nateglinide,Pioglitazone,Repaglinide,Rosiglitazone,Sulfasalazine,Telmisartan,Troglitazone,difluoro(5-{2-(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene-2H-pyrrol-5-yl-kappaN}pentanoato)boron		0.00001	8089.73	C=1002, G=894		C=529/473, G=472/422	6	
chr3:37067240	T/A	T	SNV		MLH1	exonic	1								47.79	p.Val384Asp		1852	T=0.5221, A=0.4779		Present				+	12	NM_000249.3	c.1151T>A	missense	2.16	0.0	152.0	1.0	DNA mismatch repair protein,Histidine kinase-	rs63750447		0.009 (ref)	1.0E-4	0.0	1.0E-4		ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,MutLalpha complex,MutLbeta complex,MutSalpha complex binding,cell cycle,cellular response to organic cyclic compound,chiasma,double-strand break repair via nonhomologous end joining,guanine/thymine mispair binding,isotype switching,male germ cell nucleus,male meiosis chromosome segregation,meiotic metaphase I plate congression,mismatch repair,mismatched DNA binding,negative regulation of mitotic recombination,nuclear-transcribed mRNA poly(A) tail shortening,nucleus,oogenesis,pachytene,protein binding,reciprocal meiotic recombination,resolution of meiotic recombination intermediates,response to drug,response to hypoxia,response to toxin,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,spermatogenesis,spindle midzone assembly involved in meiosis,synaptonemal complex		non-pathogenic	0.00001	8057.19	T=967, A=885		T=486/481, A=438/447	2	
chr3:47125385	G/A	G	SNV		SETD2	exonic	1								52.15	p.Pro1962Leu		1998	G=0.4785, A=0.5215		Present				-	12	NM_014159.6	c.5885C>T	missense	0.33	0.06	98.0	0.0	SET domain,WW domain	rs4082155		0.496 (ref)	0.4338	0.2862	0.4713	YES	DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	10051.5	G=956, A=1042		G=531/425, A=536/506	3	
chr3:47162661	A/G	A	SNV		SETD2	exonic	1								56.30	p.(=)		1977	A=0.437, G=0.563		Present				-	3	NM_014159.6	c.3465T>C	synonymous	-0.59				SET domain,WW domain	rs6767907		0.316 (ref)	0.4088	0.2506	0.3552	YES	DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	11244.9	A=864, G=1113		A=433/431, G=583/530	1	
chr3:178927980	T/C	T	SNV		PIK3CA	exonic	1	Hotspot	Gain-of-function			HS	COSM757		28.52	p.Cys420Arg		1655	T=0.7148, C=0.2852		Present				+	8	NM_006218.2	c.1258T>C	missense	2.11	0.06	180.0	0.997	PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family	rs121913272							1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE	other	0.00001	2787.77	T=1183, C=472		T=537/646, C=236/236	1	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1307	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	19780.3	G=0, A=1307		G=0/0, A=649/658	1	
chr4:55141051	GCCCGGATGGACATGA/GCCCGGATGGACATGA	GCCCAGATGGACATGA	SNV		PDGFRA	exonic	1					HS	COSM12418		G=0.00, GCCCGGATGGACATGA=100.00	p.(=)		1819	GCCCAGATGGACATGA=0.0, G=0.0, GCCCGGATGGACATGA=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	2.79,2.74,2.74,2.74,-5.31,2.74,2.21,0.99,2.74,2.74,0.41,2.64,2.31,-0.28,1.57,2.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778,rs201503614		0.037				YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	26164.1	GCCCAGATGGACATGA=0, G=0, GCCCGGATGGACATGA=1819		GCCCAGATGGACATGA=0/0, G=0/0, GCCCGGATGGACATGA=861/958	3,1	
chr5:38955796	G/A	G	SNV		RICTOR	exonic	1								44.59	p.Ser837Phe		1339	G=0.5541, A=0.4459		Present				-	26	NM_152756.4	c.2510C>T	missense	1.26	0.7	155.0	0.002		rs2043112		0.392 (ref)	0.401	0.2853	0.3618	YES	T cell costimulation,TORC2 complex,actin cytoskeleton reorganization,cytosol,embryo development,fibroblast growth factor receptor signaling pathway,nerve growth factor receptor signaling pathway,phosphatidylinositol-mediated signaling,positive regulation of TOR signaling cascade,positive regulation of actin filament polymerization,positive regulation of peptidyl-tyrosine phosphorylation,protein binding,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of protein kinase B signaling cascade,ribosome binding			0.00001	5210.81	G=742, A=597		G=371/371, A=280/317	2	
chr5:67522722	T/T	C	SNV		PIK3R1	exonic	1								100.00	p.(=)		1171	C=0.0, T=1.0		Present				+	2	NM_181523.2	c.219C>T	synonymous	-2.42				RhoGAP domain,SH2 domain,SH3 domain	rs706713		0.442 (ref)	0.234	0.4092	0.2933	YES	1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol		0.00001	17710.2	C=0, T=1171		C=0/0, T=573/598	1	
chr5:67589188	C/T	C	SNV		PIK3R1	exonic	1								56.05	p.(=)		1529	C=0.4395, T=0.5605		Present				+	10	NM_181523.2	c.1176C>T	synonymous	1.57				RhoGAP domain,SH2 domain,SH3 domain	rs3730090		0.308 (ref)				YES	1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol		0.00001	8564.29	C=672, T=857		C=300/372, T=397/460	1	
chr5:176516631	G/A	G	SNV		FGFR4	exonic	1								44.94	p.Val10Ile		968	G=0.5506, A=0.4494		Present				+	2	NM_213647.1	c.28G>A	missense	-0.41	0.35	29.0	0.0	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs1966265		0.249 (ref)	0.227	0.0611	0.1708	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	3802.92	G=533, A=435		G=259/274, A=204/231	5	
chr5:176520243	G/A	G	SNV		FGFR4	exonic	1								51.64	p.Gly388Arg		1278	G=0.4836, A=0.5164		Present				+	9	NM_213647.1	c.1162G>A	missense	2.23	0.0	125.0	0.998	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs351855		0.303 (ref)	0.3006	0.1287	0.2423	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin	pathogenic	0.00001	6291.06	G=618, A=660		G=310/308, A=314/346	3	
chr6:41903782	C/C	A	SNV		CCND3	exonic	1								100.00	p.Ser259Ala		1661	A=0.0, C=1.0		Present				-	5	NM_001760.4	c.775T>G	missense	-0.25	0.59	99.0	0.0	Cyclin	rs1051130		0.415 (ref)	0.4535	0.2238	0.3757	YES	T cell proliferation,cell division,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,membrane,nucleus,positive regulation of cyclin-dependent protein kinase activity,positive regulation of protein phosphorylation,protein binding,protein kinase binding,regulation of cell cycle,signal transduction			0.00001	25282.3	A=0, C=1661		A=0/0, C=743/918	1	
chr6:152201875	C/C	T	SNV		ESR1	exonic	1								100.00	p.(=)		908	T=0.0, C=1.0		Present				+	4	NM_001122740.1	c.729T>C	synonymous	0.22				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs4986934		0.018 (ref)	0.04	0.0082	0.0292	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	13807.5	T=0, C=908		T=0/0, C=380/528	1	
chr7:6013049	C/G	C	SNV		PMS2	exonic	1								67.13	p.Gly857Ala		1734	C=0.3287, G=0.6713		Present				-	15	NM_000535.5	c.2570G>C	missense	0.33	0.19	60.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs1802683		0.173 (ref)				YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic,probable-non-pathogenic	0.00001	13053.0	C=570, G=1164		C=363/207, G=718/446	3	
chr7:6026775	C/C	T	SNV		PMS2	exonic	1								100.00	p.Lys541Glu		1986	T=0.0, C=1.0		Present				-	11	NM_000535.5	c.1621A>G	missense	0.74	1.0	56.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs2228006		0.121 (ref)	0.1543	0.0815	0.1296	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester		0.00001	29988.1	T=0, C=1986		T=0/0, C=983/1003	4	
chr7:6026988	G/A	G	SNV		PMS2	exonic	1								53.80	p.Pro470Ser		2000	G=0.462, A=0.538		Present				-	11	NM_000535.5	c.1408C>T	missense	0.39	0.51	74.0	0.002	DNA mismatch repair protein,Histidine kinase-	rs1805321		0.394 (ref)	0.4209	0.2819	0.3738	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	10575.6	G=924, A=1076		G=472/452, A=546/530	2	
chr7:6036980	C/C	G	SNV		PMS2	exonic	1								100.00	p.(=)		1996	G=0.0, C=1.0		Present				-	7	NM_000535.5	c.780C>G	synonymous	-5.63				DNA mismatch repair protein,Histidine kinase-	rs1805319		0.157 (ref)	0.1852	0.1586	0.1762	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	30338.5	G=0, C=1996		G=0/0, C=955/1041	2	
chr7:6043386	G/A	G	SNV		PMS2	exonic	1								86.67	p.(=)		135	G=0.1333, A=0.8667		Present				-	4	NM_000535.5	c.288C>T	synonymous	-0.41				DNA mismatch repair protein,Histidine kinase-	rs12532895		0.113 (ref)	0.0277	0.019	0.0245	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	untested	0.00001	1507.55	G=18, A=117		G=14/4, A=110/7	2	
chr7:55242467	AATTAAGAGAAGCAACATCTCC/AATCTCC	AATTAAGAGAAGCAACATCTCC	INDEL		EGFR	exonic	15	Hotspot	Gain-of-function			HS	COSM144207;COSM28623;COSM53205;COSM18421;COSM12369;COSM12386;COSM133193;COSM52935;COSM12416;COSM6220;COSM12384;COSM18426;COSM674057;COSM18427;COSM51524		CACCAACATCTCC=0.00, TCCCTACATCTCC=0.00, TGGCATCTCC=0.00, TTCCATCTCC=0.00, AATCTCC=25.18, TATCTCC=0.00, TCTCTCC=0.00, TTCCTTCTCC=0.00, TTGCTTCTCC=0.00, ATCC=0.00, TTCC=0.00, TCCC=0.00, TGCC=0.00, TCTC=0.00, TTCA=0.00	p.Leu747_Thr751del		1958	AATTAAGAGAAGCAACATCTCC=0.7482, CACCAACATCTCC=0.0, TCCCTACATCTCC=0.0, TGGCATCTCC=0.0, TTCCATCTCC=0.0, AATCTCC=0.2518, TATCTCC=0.0, TCTCTCC=0.0, TTCCTTCTCC=0.0, TTGCTTCTCC=0.0, ATCC=0.0, TTCC=0.0, TCCC=0.0, TGCC=0.0, TCTC=0.0, TTCA=0.0		Present				+	19	NM_005228.3	c.2240_2254delTAAGAGAAGCAACAT	nonframeshiftDeletion	0.98,-0.2,0.39,2.07,-1.46,-0.61,2.56,0.07,2.56,2.07,0.39,2.56,2.56,-0.63,2.07,2.56,-2.87,2.07,1.3,0.86,2.56,2.56				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121913229,rs121913231,rs121913421,rs121913422,rs121913423,rs121913424,rs121913425,rs121913426,rs121913435,rs121913436,rs121913437,rs121913438,rs121913439,rs121913440,rs121913441,rs121913442,rs121913463,rs121913464							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	2640.68	AATTAAGAGAAGCAACATCTCC=1465, CACCAACATCTCC=0, TCCCTACATCTCC=0, TGGCATCTCC=0, TTCCATCTCC=0, AATCTCC=493, TATCTCC=0, TCTCTCC=0, TTCCTTCTCC=0, TTGCTTCTCC=0, ATCC=0, TTCC=0, TCCC=0, TGCC=0, TCTC=0, TTCA=0		AATTAAGAGAAGCAACATCTCC=744/721, CACCAACATCTCC=0/0, TCCCTACATCTCC=0/0, TGGCATCTCC=0/0, TTCCATCTCC=0/0, AATCTCC=253/240, TATCTCC=0/0, TCTCTCC=0/0, TTCCTTCTCC=0/0, TTGCTTCTCC=0/0, ATCC=0/0, TTCC=0/0, TCCC=0/0, TGCC=0/0, TCTC=0/0, TTCA=0/0	2,2,2,2,2,2,2,2,2,2,2,2,2,2,2	
chr7:55266417	C/C	T	SNV		EGFR	exonic	1								100.00	p.(=)		1988	T=0.0, C=1.0		Present				+	23	NM_005228.3	c.2709T>C	synonymous	-1.92				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1140475		0.095 (ref)	0.1267	0.0801	0.1109	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	30111.1	T=0, C=1988		T=0/0, C=1066/922	1	
chr7:55269048		G	GENE_EXPRESSION		EGFR								EGFR-EGFR.E25E18.KDD				82				NoCall			1.9294e-07																						0.0					
chr7:116435768	T/T	C	SNV		MET	exonic	1								100.00	p.(=)		1950	C=0.0, T=1.0		Present				+	20	NM_001127500.1	c.3912C>T	synonymous	-3.37				IPT/TIG domain,Plexin repeat,Protein kinase domain,Protein tyrosine kinase,Sema domain	rs41736		0.372 (ref)	0.4243	0.1041	0.3235	YES	ATP binding,axon guidance,basal plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,hepatocyte growth factor receptor signaling pathway,hepatocyte growth factor-activated receptor activity,integral to membrane,integral to plasma membrane,multicellular organismal development,nucleotide binding,plasma membrane,protein binding,protein tyrosine kinase activity,receptor activity,signal transduction	1-(2-NITROPHENYL)SULFONYL-1H-PYRROLO3,2-BPYRIDINE-6-CARBOXAMIDE,1-(4-fluorophenyl)-N-3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenyl-2-oxo-1,2-dihydropyridine-3-carboxamide,2-(4-fluorophenyl)-N-{3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenylcarbamoyl}acetamide,3-(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine,3-3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-ylphenol,6-{6-(1-methyl-1H-pyrazol-4-yl)1,2,4triazolo4,3-bpyridazin-3-ylsulfanyl}quinoline,K-252a,N-(3-chlorophenyl)-N-methyl-2-oxo-3-(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl-2H-indole-5-sulfonamide,N-({4-(2-aminopyridin-4-yl)oxy-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide		0.00001	29553.6	C=0, T=1950		C=0/0, T=997/953	1	
chr7:116436022	A/A	G	SNV		MET	exonic	1								100.00	p.(=)		1871	G=0.0, A=1.0		Present				+	21	NM_001127500.1	c.4071G>A	synonymous	-3.55				IPT/TIG domain,Plexin repeat,Protein kinase domain,Protein tyrosine kinase,Sema domain	rs2023748		0.373 (ref)	0.4268	0.1029	0.3225	YES	ATP binding,axon guidance,basal plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,hepatocyte growth factor receptor signaling pathway,hepatocyte growth factor-activated receptor activity,integral to membrane,integral to plasma membrane,multicellular organismal development,nucleotide binding,plasma membrane,protein binding,protein tyrosine kinase activity,receptor activity,signal transduction	1-(2-NITROPHENYL)SULFONYL-1H-PYRROLO3,2-BPYRIDINE-6-CARBOXAMIDE,1-(4-fluorophenyl)-N-3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenyl-2-oxo-1,2-dihydropyridine-3-carboxamide,2-(4-fluorophenyl)-N-{3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenylcarbamoyl}acetamide,3-(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine,3-3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-ylphenol,6-{6-(1-methyl-1H-pyrazol-4-yl)1,2,4triazolo4,3-bpyridazin-3-ylsulfanyl}quinoline,K-252a,N-(3-chlorophenyl)-N-methyl-2-oxo-3-(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl-2H-indole-5-sulfonamide,N-({4-(2-aminopyridin-4-yl)oxy-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide		0.00001	28368.8	G=0, A=1871		G=0/0, A=966/905	1	
chr7:140449150	T/C	T	SNV		BRAF	exonic	1								50.90	p.(=)		2000	T=0.491, C=0.509		Present				-	16	NM_004333.4	c.1929A>G	synonymous	-0.01				C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain	rs9648696		0.28 (ref)	0.1463	0.3409	0.32	YES	ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib		0.00001	9672.29	T=982, C=1018		T=512/470, C=507/511	2	
chr8:90958422	T/C	T	SNV		NBN	exonic	1								45.57	p.(=)		1999	T=0.5443, C=0.4557		Present				-	13	NM_002485.4	c.2016A>G	synonymous	-1.06				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1061302		0.328 (ref)	0.3132	0.2276	0.2842	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	8080.4	T=1088, C=911		T=554/534, C=460/451	1	
chr8:90967711	G/G	A	SNV		NBN	exonic	1								100.00	p.(=)		1684	A=0.0, G=1.0		Present				-	10	NM_002485.4	c.1197T>C	synonymous	-0.48				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs709816		0.424 (ref)	0.3559	0.2473	0.4903	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	25259.6	A=0, G=1684		A=0/0, G=901/783	1	
chr8:90971041	C/T	C	SNV		NBN	exonic	1								56.61	p.Val346Met		1906	C=0.4339, T=0.5661		Present				-	9	NM_002485.4	c.1036G>A	missense	0.46	0.12	21.0	0.002	BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs200297914		0.001 (ref)					ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	10915.2	C=827, T=1079		C=373/454, T=519/560	1	
chr8:90990479	C/G	C	SNV		NBN	exonic	1								43.65	p.Glu185Gln		1118	C=0.5635, G=0.4365		Present				-	5	NM_002485.4	c.553G>C	missense	0.09	1.0	29.0	0.0	BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1805794		0.333 (ref)	0.3136	0.2338	0.2866	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	4225.36	C=630, G=488		C=334/296, G=263/225	1	
chr8:90995019	C/T	C	SNV		NBN	exonic	1								42.60	p.(=)		2000	C=0.574, T=0.426		Present				-	2	NM_002485.4	c.102G>A	synonymous	-0.39				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1063045		0.35 (ref)	0.3147	0.3103	0.3132	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	7254.52	C=1148, T=852		C=576/572, T=430/422	1	
chr9:21971134	G/A	G	SNV		CDKN2A	exonic	1								7.89	p.Pro75Leu		38	G=0.9211, A=0.0789		Present				-	2	NM_000077.4	c.224C>T	missense	2.73	0.04	98.0	1.0	Cyclin-dependent kinase inhibitor 2a p19Arf N-terminus								G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,NF-kappaB binding,Ras protein signal transduction,cell aging,cell cycle arrest,cell cycle checkpoint,cyclin-dependent protein kinase inhibitor activity,cytoplasm,cytosol,epidermis development,induction of apoptosis,mitotic cell cycle,negative regulation of NF-kappaB transcription factor activity,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of cell-matrix adhesion,negative regulation of cyclin-dependent protein kinase activity,negative regulation of mammary gland epithelial cell proliferation,negative regulation of phosphorylation,negative regulation of transcription, DNA-dependent,nucleolus,nucleoplasm,nucleus,positive regulation of apoptosis involved in mammary gland involution,positive regulation of cellular senescence,positive regulation of macrophage apoptosis,positive regulation of smooth muscle cell apoptosis,protein binding,protein kinase binding,rRNA transcription,regulation of nucleocytoplasmic transport,replicative senescence,senescence-associated heterochromatin focus,senescence-associated heterochromatin focus assembly,sequence-specific DNA binding transcription factor activity			0.04081	13.8925	G=35, A=3		G=24/11, A=1/2	4	
chr9:98209594	G/A	G	SNV		PTCH1	exonic	1								45.82	p.Pro1315Leu		718	G=0.5418, A=0.4582		Present				-	23	NM_000264.3	c.3944C>T	missense	2.51	0.0	98.0	0.906	Patched family	rs357564		0.382 (ref)	0.3298	0.2389	0.2993	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	2940.91	G=389, A=329		G=185/204, A=137/192	6	
chr9:98229389	C/G	C	SNV		LOC100507346,PTCH1	intronic, exonic_nc	1								49.26			1547	C=0.5074, G=0.4926		Present				-, +		NM_000264.3, NR_038982.1			-0.28				Patched family	rs2066829		0.399 (ref)	0.3645	0.3715	0.4539	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	7080.41	C=785, G=762		C=373/412, G=379/383	2	
chr9:98231008	A/G	A	SNV		LOC100507346,PTCH1	intronic, exonic_nc	1								49.63			1368	A=0.5037, G=0.4963		Present				-, +		NM_000264.3, NR_038982.1			0.65				Patched family	rs16909898		0.101 (ref)	0.0897	0.1389	0.1063	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	6318.26	A=689, G=679		A=433/256, G=411/268	2	
chr9:98238379	A/G	A	SNV		PTCH1	exonic	1								48.81	p.(=)		1518	A=0.5119, G=0.4881		Present				-	12	NM_000264.3	c.1665T>C	synonymous	-0.69				Patched family	rs1805155		0.12 (ref)	0.1035	0.1845	0.1309	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	6864.16	A=777, G=741		A=412/365, G=379/362	1	
chr9:139390834	C/T	C	SNV		NOTCH1	exonic	1								53.97	p.Val2453Met		730	C=0.4603, T=0.5397		Present				-	34	NM_017617.3	c.7357G>A	missense	0.77	0.16	21.0	0.549	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein								Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	3846.68	C=336, T=394		C=180/156, T=231/163	2	
chr9:139391636	G/A	G	SNV		NOTCH1	exonic	1								46.53	p.(=)		806	G=0.5347, A=0.4653		Present				-	34	NM_017617.3	c.6555C>T	synonymous	-0.09				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229974		0.305 (ref)	0.4467	0.3639	0.4187	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	3342.04	G=431, A=375		G=252/179, A=211/164	1	
chr9:139397707	G/A	G	SNV		NOTCH1	exonic	1								54.85	p.(=)		753	G=0.4515, A=0.5485		Present				-	27	NM_017617.3	c.5094C>T	synonymous	-0.82				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs10521		0.417 (ref)	0.3534	0.4829	0.408	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	4107.39	G=340, A=413		G=195/145, A=226/187	1	
chr9:139399249	T/C	T	SNV		NOTCH1	exonic	1								47.40	p.Lys1632Glu		327	T=0.526, C=0.474		Present				-	26	NM_017617.3	c.4894A>G	missense	0.1	0.32	56.0	0.27	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein								Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	1386.05	T=172, C=155		T=65/107, C=62/93	2	
chr9:139407932	G/G	A	SNV		NOTCH1	exonic	1								100.00	p.(=)		1989	A=0.0, G=1.0		Present				-	14	NM_017617.3	c.2265T>C	synonymous	-1.25				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229971		0.444 (ref)	0.2858	0.3844	0.3975	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	30239.4	A=0, G=1989		A=0/0, G=1020/969	1	
chr9:139418260	G/G	A	SNV		NOTCH1	exonic	1								100.00	p.(=)		554	A=0.0, G=1.0		Present				-	3	NM_017617.3	c.312T>C	synonymous	-1.16				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs4489420		0.293 (ref)	0.4711	0.1191	0.3913	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	8399.57	A=0, G=554		A=0/0, G=273/281	1	
chr10:43613843	G/T	G	SNV		RET	exonic	1								52.43	p.(=)		637	G=0.4757, T=0.5243		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	3009.78	G=303, T=334		G=123/180, T=147/187	1	
chr10:123298158	T/C	T	SNV		FGFR2	exonic	1								55.93	p.(=)		1502	T=0.4407, C=0.5593		Present				-	6	NM_000141.4	c.696A>G	synonymous	0.96				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs1047100		0.176 (ref)	0.2236	0.2522	0.2333	YES	ATP binding,Golgi apparatus,angiogenesis,apoptotic process,axonogenesis,bone development,bone mineralization,bone morphogenesis,branch elongation involved in salivary gland morphogenesis,branching involved in embryonic placenta morphogenesis,branching involved in prostate gland morphogenesis,branching involved in salivary gland morphogenesis,branching morphogenesis of a nerve,bud elongation involved in lung branching,cell cortex,cell fate commitment,cell surface,cell-cell signaling,cytoplasm,cytoplasmic membrane-bounded vesicle,digestive tract development,embryonic digestive tract morphogenesis,embryonic organ development,embryonic organ morphogenesis,embryonic pattern specification,epidermis morphogenesis,epithelial cell differentiation,epithelial cell proliferation involved in salivary gland morphogenesis,excitatory synapse,extracellular matrix,extracellular region,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,fibroblast growth factor-activated receptor activity,gland morphogenesis,hair follicle morphogenesis,heparin binding,in utero embryonic development,inner ear morphogenesis,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,lacrimal gland development,lateral sprouting from an epithelium,limb bud formation,lung alveolus development,lung development,lung lobe morphogenesis,lung-associated mesenchyme development,mammary gland bud formation,membrane,membranous septum morphogenesis,mesenchymal cell differentiation,mesenchymal cell differentiation involved in lung development,mesenchymal cell proliferation involved in lung development,midbrain development,morphogenesis of embryonic epithelium,multicellular organism growth,negative regulation of transcription from RNA polymerase II promoter,nucleotide binding,nucleus,odontogenesis,orbitofrontal cortex development,organ growth,organ morphogenesis,otic vesicle formation,outflow tract septum morphogenesis,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Wnt receptor signaling pathway,positive regulation of canonical Wnt receptor signaling pathway,positive regulation of cardiac muscle cell proliferation,positive regulation of cell cycle,positive regulation of cell division,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of epithelial cell proliferation involved in lung morphogenesis,positive regulation of mesenchymal cell proliferation,positive regulation of phospholipase activity,positive regulation of transcription from RNA polymerase II promoter,post-embryonic development,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,prostate gland morphogenesis,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,pyramidal neuron development,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of branching involved in prostate gland morphogenesis,regulation of cell fate commitment,regulation of fibroblast growth factor receptor signaling pathway,regulation of morphogenesis of a branching structure,regulation of multicellular organism growth,regulation of osteoblast differentiation,regulation of osteoblast proliferation,regulation of smooth muscle cell differentiation,regulation of smoothened signaling pathway,reproductive structure development,skeletal system morphogenesis,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,ureteric bud development,ventricular cardiac muscle tissue morphogenesis,ventricular zone neuroblast division	4-4-(1-Amino-1-Methylethyl)Phenyl-5-Chloro-N-4-(2-Morpholin-4-Ylethyl)PhenylPyrimidin-2-Amine,Palifermin,SU4984,Thalidomide		0.00001	8425.49	T=662, C=840		T=354/308, C=419/421	1	
chr11:534242	A/G	A	SNV		HRAS	exonic	1								48.97	p.(=)		1064	A=0.5103, G=0.4897		Present				-	2	NM_001130442.1	c.81T>C	synonymous	-0.0				Miro-like protein,Ras family	rs12628		0.297 (ref)	0.3441	0.3749	0.3545	YES	GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,apoptotic process,axon guidance,blood coagulation,cell cycle arrest,cell surface receptor linked signaling pathway,cellular senescence,chemotaxis,cytoplasm,cytosol,endocytosis,epidermal growth factor receptor signaling pathway,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,leukocyte migration,membrane fraction,microsome,mitotic cell cycle G1/S transition checkpoint,negative regulation of cell proliferation,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,protein C-terminus binding,protein binding,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,social behavior,soluble fraction,striated muscle cell differentiation,synaptic transmission,visual learning	Guanosine-5'-Diphosphate,Guanosine-5'-Triphosphate,Hexane-1,6-Diol,N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE,Trifluoroethanol		0.00001	4821.83	A=543, G=521		A=243/300, G=262/259	4	
chr11:108183167	G/G	A	SNV		ATM	exonic	1								100.00	p.Asn1983Ser		1983	A=0.0, G=1.0		Present				+	40	NM_000051.3	c.5948A>G	missense	-0.19	1.0	46.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase	rs659243		0.0 (ref)					1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.00001	29867.4	A=0, G=1983		A=0/0, G=935/1048	2	
chr11:125525195	G/G	A	SNV		CHEK1	exonic	1								100.00	p.Ile471Val		1996	A=0.0, G=1.0		Present				+	13	NM_001274.5	c.1411A>G	missense	0.45	1.0	29.0	0.0	Protein kinase domain,Protein tyrosine kinase	rs506504		0.017 (ref)	0.0363	0.0064	0.0262	YES	ATP binding,DNA damage checkpoint,DNA damage induced protein phosphorylation,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,G2/M transition of mitotic cell cycle,cell cycle,cell cycle checkpoint,cellular response to caffeine,cellular response to mechanical stimulus,cellular response to organic substance,centrosome,chromatin,chromatin-mediated maintenance of transcription,chromosome, telomeric region,condensed nuclear chromosome,cytoplasm,cytoskeleton,histone H3-T11 phosphorylation,histone kinase activity (H3-T11 specific),negative regulation of mitosis,nucleoplasm,nucleotide binding,nucleus,peptidyl-threonine phosphorylation,protein binding,protein serine/threonine kinase activity,regulation of S phase,regulation of double-strand break repair via homologous recombination,regulation of histone H3-K9 acetylation,regulation of mitotic centrosome separation,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,replication fork,replicative senescence,response to DNA damage stimulus	(2R)-1-(5,6-DIPHENYL-7H-PYRROLO2,3-DPYRIMIDIN-4-YL)AMINOPROPAN-2-OL,(2R)-3-{(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO2,3-DPYRIMIDIN-4-YLIDENEAMINO}PROPANE-1,2-DIOL,(2S)-1-AMINO-3-(5-NITROQUINOLIN-8-YL)AMINOPROPAN-2-OL,(3-ENDO)-8-METHYL-8-AZABICYCLO3.2.1OCT-3-YL 1H-PYRROLO2,3-BPYRIDINE-3-CARBOXYLATE,(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE,(5,6-DIPHENYL-FURO2,3-DPYRIMIDIN-4-YLAMINO)-ACETIC,(5-{3-5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL,1-(2S)-4-(5-BROMO-1H-PYRAZOLO3,4-BPYRIDIN-4-YL)MORPHOLIN-2-YLMETHANAMINE,1-(2S)-4-(5-phenyl-1H-pyrazolo3,4-bpyridin-4-yl)morpholin-2-ylmethanamine,1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-2-(DIMETHYLAMINO)-1-METHYLETHOXYPYRAZIN-2-YL}UREA,18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE,2,2'-{9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYLBIS(OXY)}DIACETIC ACID,2-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)AMINOETHANOL,2-(cyclohexylamino)benzoic acid,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,2-5,6-BIS-(4-METHOXY-PHENYL)-FURO2,3-DPYRIMIDIN-4-YLAMINO-ETHANOL,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,3-AMINO-3-BENZYL-4.3.0BICYCLO-1,6-DIAZANONAN-2-ONE,4-(3S)-1-AZABICYCLO2.2.2OCT-3-YLAMINO-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,4-(6-{(4-METHYLCYCLOHEXYL)AMINOMETHYL}-1,4-DIHYDROINDENO1,2-CPYRAZOL-3-YL)BENZOIC ACID,4-3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL-2-METHOXYPHENOL,4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl(phenyl)methanone,5,6,7,8-TETRAHYDRO1BENZOTHIENO2,3-DPYRIMIDIN-4(3H)-ONE,5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO4,3-CQUINOLIN-4-ONE,6-MORPHOLIN-4-YL-9H-PURINE,N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-1,3THIAZOLO5,4-CAZEPIN-2-YL)ACETAMIDE,N-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)GLYCINE,N-{5-4-(4-METHYLPIPERAZIN-1-YL)PHENYL-1H-PYRROLO2,3-BPYRIDIN-3-YL}NICOTINAMIDE,REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO1,2,3-FG:3',2',1'-KLPYRROLO3,4-I1,6BENZODIAZOCINE-1,3(2H)-DIONE		0.00001	30431.1	A=0, G=1996		A=0/0, G=922/1074	1	
chr12:25368462	T/T	C	SNV		KRAS	exonic	1								100.00	p.(=)		1988	C=0.0, T=1.0		Present				-	5	NM_033360.3	c.483G>A	synonymous	1.06				Miro-like protein,Ras family	rs4362222		0.0 (ref)	0.0	0.0043	0.0015		GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE		0.00001	30047.7	C=0, T=1988		C=0/0, T=1070/918	3	
chr12:133208979	C/C	T	SNV		POLE	exonic	1								100.00	p.(=)		1454	T=0.0, C=1.0		Present				-	45	NM_006231.3	c.6252A>G	synonymous	-2.14				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5745022		0.307 (ref)	0.4157	0.2433	0.3573	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	22091.1	T=0, C=1454		T=0/0, C=692/762	1	
chr12:133219831	C/C	T	SNV		POLE	exonic	1								100.00	p.(=)		1119	T=0.0, C=1.0		Present				-	35	NM_006231.3	c.4530A>G	synonymous	-2.11				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744944		0.416 (ref)	0.4306	0.2985	0.4776	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	16912.6	T=0, C=1119		T=0/0, C=485/634	1	
chr12:133236000	T/T	C	SNV		POLE	exonic	1								100.00	p.(=)		1997	C=0.0, T=1.0		Present				-	26	NM_006231.3	c.3156G>A	synonymous	-3.0				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744857		0.416 (ref)	0.4307	0.2985	0.4775	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	30406.0	C=0, T=1997		C=0/0, T=942/1055	1	
chr13:28636084	A/A	G	SNV		FLT3	exonic	1								100.00	p.(=)		1998	G=0.0, A=1.0		Present				-	3	NM_004119.2	c.288C>T	synonymous	0.04				Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7338903		0.041 (ref)	0.0105	0.0978	0.0401	YES	ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity	Sorafenib,Sunitinib		0.00001	30467.6	G=0, A=1998		G=0/0, A=996/1002	1	
chr13:32906729	A/C	A	SNV		BRCA2	exonic	1								39.40	p.Asn372His		1995	A=0.606, C=0.394		Present				+	10	NM_000059.3	c.1114A>C	missense	-0.15	0.15	68.0	0.023	BRCA2 repeat	rs144848		0.24 (ref)	0.2859	0.1289	0.2332	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		non-pathogenic,other	0.00001	6370.72	A=1209, C=786		A=613/596, C=381/405	3	
chr13:32913055	G/G	A	SNV		BRCA2	exonic	1								100.00	p.(=)		1722	A=0.0, G=1.0		Present				+	11	NM_000059.3	c.4563A>G	synonymous	0.6				BRCA2 repeat	rs206075		0.026 (ref)	6.0E-4	0.0704	0.0242	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	26125.9	A=0, G=1722		A=0/0, G=859/863	1	
chr13:32914277	A/G	A	SNV		BRCA2	exonic	1								61.60	p.Ile1929Val		1521	A=0.384, G=0.616		Present				+	11	NM_000059.3	c.5785A>G	missense	-0.94	0.44	29.0	0.012	BRCA2 repeat	rs79538375		0.001 (ref)	1.0E-4	0.0	1.0E-4		BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		non-pathogenic	0.00001	9936.5	A=584, G=937		A=294/290, G=436/501	3	
chr13:32915005	C/C	G	SNV		BRCA2	exonic	1								100.00	p.(=)		1995	G=0.0, C=1.0		Present				+	11	NM_000059.3	c.6513G>C	synonymous	-1.1				BRCA2 repeat	rs206076		0.026 (ref)	6.0E-4	0.0713	0.0245	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	30398.2	G=0, C=1995		G=0/0, C=1060/935	1	
chr13:32929387	C/C	T	SNV		BRCA2	exonic	1								100.00	p.Val2466Ala		1449	T=0.0, C=1.0		Present				+	14	NM_000059.3	c.7397T>C	missense	1.27	0.58	64.0	0.0	BRCA2 repeat	rs169547		0.022 (ref)	6.0E-4	0.0647	0.0223	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		untested	0.00001	21763.2	T=0, C=1449		T=0/0, C=702/747	1	
chr13:32937670		G	GENE_EXPRESSION		BRCA2								BRCA2.E18E19				42				NoCall			9.8824e-08																						0.0					
chr14:105239894	C/T	C	SNV		AKT1	exonic	1								61.38	p.(=)		782	C=0.3862, T=0.6138		Present				-	9	NM_001014431.1	c.726G>A	synonymous	2.2				PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase	rs1130233		0.314 (ref)	0.2459	0.1151	0.2016	YES	ATP binding,G-protein coupled receptor signaling pathway,RNA metabolic process,T cell costimulation,activation of pro-apoptotic gene products,activation-induced cell death of T cells,anti-apoptosis,apoptotic process,blood coagulation,carbohydrate metabolic process,carbohydrate transport,cell differentiation,cell proliferation,cellular response to insulin stimulus,cytoplasm,cytosol,endocrine pancreas development,enzyme binding,fibroblast growth factor receptor signaling pathway,identical protein binding,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular signal transduction,kinase activity,mRNA metabolic process,mammary gland epithelial cell differentiation,membrane fraction,microtubule cytoskeleton,multicellular organismal development,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of fatty acid beta-oxidation,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of protein kinase activity,negative regulation of release of cytochrome c from mitochondria,nerve growth factor receptor signaling pathway,nervous system development,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric-oxide synthase regulator activity,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,phosphatidylinositol-3,4,5-trisphosphate binding,phosphatidylinositol-3,4-bisphosphate binding,phosphatidylinositol-mediated signaling,phosphorylation,plasma membrane,platelet activation,positive regulation of anti-apoptosis,positive regulation of blood vessel endothelial cell migration,positive regulation of cell growth,positive regulation of cellular protein metabolic process,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of establishment of protein localization in plasma membrane,positive regulation of fat cell differentiation,positive regulation of glucose import,positive regulation of glucose metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of lipid biosynthetic process,positive regulation of nitric oxide biosynthetic process,positive regulation of nitric-oxide synthase activity,positive regulation of peptidyl-serine phosphorylation,positive regulation of protein phosphorylation,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,protein binding,protein import into nucleus, translocation,protein kinase activity,protein modification process,protein phosphorylation,protein serine/threonine kinase activity,regulation of G1/S transition checkpoint,regulation of cell migration,regulation of glycogen biosynthetic process,regulation of neuron projection development,regulation of nitric-oxide synthase activity,regulation of translation,response to UV-A,response to fluid shear stress,response to heat,signal transduction,transport	5-(5-chloro-7H-pyrrolo2,3-dpyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo4,5-cpyridine,Adenosine triphosphate,Arsenic trioxide,Inositol 1,3,4,5-Tetrakisphosphate,N-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl-7H-pyrrolo2,3-dpyrimidin-4-amine		0.00001	5073.46	C=302, T=480		C=144/158, T=220/260	1	
chr15:89804043	C/T	C	SNV		FANCI	exonic	1								54.59	p.Ala86Val		1482	C=0.4541, T=0.5459		Present				+	4	NM_001113378.1	c.257C>T	missense	2.53	0.2	64.0	0.191		rs17803620		0.285 (ref)	0.3843	0.0948	0.2863	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	7979.94	C=673, T=809		C=349/324, T=433/376	1	
chr15:89834846	A/C	A	SNV		FANCI	exonic	1								37.22	p.Leu631Phe		1236	A=0.6278, C=0.3722		Present				+	20	NM_001113378.1	c.1893A>C	missense	-0.4	0.47	22.0	0.295		rs118138806		0.006 (ref)					DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	3581.16	A=776, C=460		A=453/323, C=303/157	4	
chr15:89836228	G/C	G	SNV		FANCI	exonic	1								54.73	p.Cys742Ser		1067	G=0.4527, C=0.5473		Present				+	22	NM_001113378.1	c.2225G>C	missense	2.79	0.66	112.0	0.007		rs2283432		0.291 (ref)	0.3895	0.0953	0.2899	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	5791.37	G=483, C=584		G=282/201, C=314/270	1	
chr15:89838236	A/A	G	SNV		FANCI	exonic	1								100.00	p.(=)		1977	G=0.0, A=1.0		Present				+	24	NM_001113378.1	c.2547G>A	synonymous	0.3					rs7183618		0.027 (ref)	0.0535	0.0087	0.0399	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	29963.2	G=0, A=1977		G=0/0, A=1017/960	2	
chr16:3639139	G/G	A	SNV		SLX4	exonic	1								100.00	p.(=)		1006	A=0.0, G=1.0		Present				-	12	NM_032444.2	c.4500T>C	synonymous	0.83				BTB/POZ domain	rs3810812		0.306 (ref)	0.4923	0.1406	0.3734	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	15244.0	A=0, G=1006		A=0/0, G=469/537	1	
chr16:3640274	G/A	G	SNV		SLX4	exonic	1								49.75	p.Pro1122Leu		1996	G=0.5025, A=0.4975		Present				-	12	NM_032444.2	c.3365C>T	missense	-0.33	1.0	98.0	0.003	BTB/POZ domain	rs714181		0.198 (ref)	0.0841	0.4613	0.2116	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	9304.89	G=1003, A=993		G=499/504, A=461/532	2	
chr16:3640784	GC/AT	GC	MNV		SLX4	exonic	2								50.61	p.Ala952Met		814	GC=0.4939, AT=0.5061		Present				-	12	NM_032444.2	c.2854_2855delGCinsAT	missense	1.36,-0.24	0.01	84.0	0.994	BTB/POZ domain	rs59939128,rs78637028		0.045,0.068	0.0647	0.0146	0.0477	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	3877.02	GC=402, AT=412		GC=204/198, AT=214/198	1	
chr16:3645607	A/G	A	SNV		SLX4	exonic	1								49.56	p.Leu671Ser		1027	A=0.5044, G=0.4956		Present				-	9	NM_032444.2	c.2012T>C	missense	0.03	1.0	145.0	0.0	BTB/POZ domain	rs77985244		0.064 (ref)	0.0677	0.0915	0.0757	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	4748.2	A=518, G=509		A=258/260, G=221/288	2	
chr16:3647692	A/C	A	SNV		SLX4	exonic	1								48.95	p.Asn457Lys		1996	A=0.5105, C=0.4895		Present				-	7	NM_032444.2	c.1371T>G	missense	1.2	1.0	94.0	0.0	BTB/POZ domain	rs74319927		0.057 (ref)	0.0676	0.0602	0.0651	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	9056.59	A=1019, C=977		A=491/528, C=421/556	1	
chr16:3650991	T/C	T	SNV		SLX4	exonic	1								46.52	p.(=)		1999	T=0.5348, C=0.4652		Present				-	5	NM_032444.2	c.1152A>G	synonymous	-4.62				BTB/POZ domain	rs112511042		0.056 (ref)	0.067	0.0617	0.0652	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	8363.22	T=1069, C=930		T=535/534, C=488/442	1	
chr16:3656625	G/A	G	SNV		SLX4	exonic	1								49.54	p.Arg204Cys		1976	G=0.5046, A=0.4954		Present				-	3	NM_032444.2	c.610C>T	missense	0.62	0.0	180.0	1.0	BTB/POZ domain	rs79842542		0.061 (ref)	0.0678	0.0781	0.0713	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	9156.45	G=997, A=979		G=504/493, A=502/477	4	
chr16:3656680	G/A	G	SNV		SLX4	exonic	1								51.53	p.(=)		1997	G=0.4847, A=0.5153		Present				-	3	NM_032444.2	c.555C>T	synonymous	0.58				BTB/POZ domain	rs74640850		0.046 (ref)	0.0677	0.0148	0.0498	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	9835.73	G=968, A=1029		G=480/488, A=505/524	1	
chr16:3778337	G/A	G	SNV		CREBBP	exonic	1								49.33	p.(=)		1202	G=0.5067, A=0.4933		Present				-	31	NM_004380.2	c.6711C>T	synonymous	-1.46				Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger	rs3751845		0.049 (ref)	0.0027	0.0575	0.0212	YES	MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE		0.00001	5495.7	G=609, A=593		G=272/337, A=295/298	3	
chr16:3795292	G/T	G	SNV		CREBBP	exonic	1								51.80	p.(=)		1884	G=0.482, T=0.518		Present				-	22	NM_004380.2	c.3900C>A	synonymous	2.79				Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger	rs129974		0.058	0.0028	0.0373	0.0145	YES	MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE		0.00001	9321.55	G=908, T=976		G=470/438, T=468/508	1	
chr16:3900610	C/T	C	SNV		CREBBP	exonic	1								49.23	p.(=)		1501	C=0.5077, T=0.4923		Present				-	2	NM_004380.2	c.486G>A	synonymous	-0.07				Bromodomain,Domain of Unknown Function (DUF902),KIX domain,TAZ zinc finger,Zinc finger								MyoD binding,N-terminal peptidyl-lysine acetylation,RNA polymerase II activating transcription factor binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,RNA polymerase II transcription coactivator activity,RNA polymerase II transcription factor binding,RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription,SMAD binding,acetyltransferase activity,cell proliferation,cellular lipid metabolic process,core promoter proximal region sequence-specific DNA binding,cytoplasm,embryonic digit morphogenesis,gene expression,histone acetylation,histone acetyltransferase activity,histone acetyltransferase complex,homeostatic process,innate immune response,interspecies interaction between organisms,metal ion binding,negative regulation of transcription from RNA polymerase II promoter,nuclear body,nuclear chromatin,nucleoplasm,nucleus,p53 binding,peroxisome proliferator activated receptor binding,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex assembly,regulation of S phase,regulation of smoothened signaling pathway,regulation of transcription, DNA-dependent,response to hypoxia,sequence-specific DNA binding transcription factor activity,signal transducer activity,signal transduction,transcription coactivator activity,transcription factor binding,transferase activity,zinc ion binding	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE		0.00001	6862.56	C=762, T=739		C=378/384, T=370/369	1	
chr16:89805914	T/C	T	SNV		FANCA,ZNF276	utr_3, exonic	1								44.55	p.Thr1328Ala		1953	T=0.5545, C=0.4455		Present				+, -	40	NM_001113525.1, NM_000135.2	c.3982A>G	missense	-0.52	0.24	58.0	0.005	Fanconi anaemia group A protein,Zinc finger,Zinc-finger associated domain (zf-AD)	rs9282681		0.084 (ref)	0.0706	0.0136	0.0513	YES	DNA binding,DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,intracellular,male gonad development,male meiosis,metal ion binding,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation,regulation of transcription, DNA-dependent,zinc ion binding			0.00001	7613.01	T=1083, C=870		T=552/531, C=418/452	1	
chr16:89807233	C/G	C	SNV		FANCA,ZNF276	utr_3, exonic	1								42.68	p.(=)		1244	C=0.5732, G=0.4268		Present				+, -	38	NM_001113525.1, NM_000135.2	c.3807G>C	synonymous	-2.02				Fanconi anaemia group A protein,Zinc finger,Zinc-finger associated domain (zf-AD)	rs11649210		0.115 (ref)	0.09	0.1431	0.108	YES	DNA binding,DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,intracellular,male gonad development,male meiosis,metal ion binding,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation,regulation of transcription, DNA-dependent,zinc ion binding			0.00001	4500.63	C=713, G=531		C=310/403, G=197/334	1	
chr16:89815152	G/A	G	SNV		FANCA	exonic	1								51.85	p.Ser1088Phe		2000	G=0.4815, A=0.5185		Present				-	33	NM_000135.2	c.3263C>T	missense	1.33	0.01	155.0	0.933	Fanconi anaemia group A protein	rs17233497		0.034 (ref)	0.081	0.0166	0.0592	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	9954.16	G=963, A=1037		G=447/516, A=461/576	1	
chr16:89825065	G/A	G	SNV		FANCA	exonic	1								53.28	p.(=)		1997	G=0.4672, A=0.5328		Present				-	30	NM_000135.2	c.2901C>T	synonymous	-0.6				Fanconi anaemia group A protein	rs17226980		0.083 (ref)	0.0809	0.0173	0.0594	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	10389.5	G=933, A=1064		G=420/513, A=430/634	2	
chr16:89836323	T/T	C	SNV		FANCA	exonic	1								100.00	p.Gly809Asp		1991	C=0.0, T=1.0		Present				-	26	NM_000135.2	c.2426G>A	missense	-0.2	0.78	94.0	0.0	Fanconi anaemia group A protein	rs7195066		0.384 (ref)	0.3142	0.3414	0.4307	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	30183.6	C=0, T=1991		C=0/0, T=1094/897	2	
chr16:89839766	G/C	G	SNV		FANCA	exonic	1								54.36	p.Pro643Ala		1422	G=0.4564, C=0.5436		Present				-	22	NM_000135.2	c.1927C>G	missense	-0.16	0.34	27.0	0.001	Fanconi anaemia group A protein	rs17232910		0.087 (ref)	0.0659	0.0125	0.0477	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	7613.64	G=649, C=773		G=199/450, C=293/480	3	
chr16:89849480	T/T	C	SNV		FANCA	exonic	1								100.00	p.Gly501Ser		1202	C=0.0, T=1.0		Present				-	16	NM_000135.2	c.1501G>A	missense	-1.69	1.0	56.0	0.0	Fanconi anaemia group A protein	rs2239359		0.393 (ref)	0.381	0.3196	0.4823	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	18136.6	C=0, T=1202		C=0/0, T=552/650	2	
chr16:89858417	C/A	C	SNV		FANCA	exonic	1								52.08	p.(=)		1999	C=0.4792, A=0.5208		Present				-	13	NM_000135.2	c.1143G>T	synonymous	-2.38				Fanconi anaemia group A protein	rs1800331		0.085 (ref)	0.081	0.0207	0.0606	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	10030.6	C=958, A=1041		C=470/488, A=504/537	1	
chr16:89866043	C/C	T	SNV		FANCA	exonic	1								100.00	p.Thr266Ala		1999	T=0.0, C=1.0		Present				-	9	NM_000135.2	c.796A>G	missense	0.38	1.0	58.0	0.0	Fanconi anaemia group A protein	rs7190823		0.343 (ref)	0.3937	0.2743	0.494	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	30474.5	T=0, C=1999		T=0/0, C=880/1119	1	
chr17:7579406	G/T	G	SNV		TP53	exonic	1	Deleterious	Loss-of-function						33.57	p.Ser94Ter		1001	G=0.6643, T=0.3357		Present				-	4	NM_000546.5	c.281C>A	nonsense	2.45				P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif								ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine		0.00001	2450.08	G=665, T=336		G=320/345, T=166/170	1	
chr17:7579472	G/C	G	SNV		TP53	exonic	1								96.21	p.Pro72Arg		1082	G=0.0379, C=0.9621		Present				-	4	NM_000546.5	c.215C>G	missense	1.36	0.6	103.0	0.083	P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif	rs1042522		0.398 (ref)	0.2548	0.4051	0.37	YES	ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	non-pathogenic	0.00001	15027.5	G=41, C=1041		G=9/32, C=437/604	6	
chr17:29508775	G/A	G	SNV		NF1	exonic	1								37.89	p.(=)		1639	G=0.6211, A=0.3789		Present				+	7	NM_001042492.2	c.702G>A	synonymous	-3.81				GTPase-activator protein for Ras-like GTPase	rs1801052		0.45 (ref)	0.2899	0.3098	0.4256	YES	MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.00001	4911.05	G=1018, A=621		G=590/428, A=363/258	1	
chr17:29553485	G/A	G	SNV		NF1	exonic	1								59.08	p.(=)		1999	G=0.4092, A=0.5908		Present				+	18	NM_001042492.2	c.2034G>A	synonymous	-2.42				GTPase-activator protein for Ras-like GTPase	rs2285892		0.471 (ref)	0.2891	0.3352	0.4163	YES	MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.00001	12278.2	G=818, A=1181		G=341/477, A=527/654	1	
chr17:33445549	G/A	G	SNV		RAD51D,RAD51L3-RFFL	intronic_nc, intronic, intronic, exonic, intronic_nc, intronic_nc	1								43.26	p.(=)		1958	G=0.5674, A=0.4326		Present				-	3	NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1	c.234C>T	synonymous	1.21					rs9901455		0.191 (ref)	0.082	0.308	0.1585	YES	ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination			0.00001	7280.18	G=1111, A=847		G=534/577, A=405/442	2	
chr17:41223094	T/C	T	SNV		BRCA1	exonic	1								40.07	p.Ser1634Gly		1999	T=0.5993, C=0.4007		Present				-	16	NM_007300.3	c.4900A>G	missense	0.13	0.03	56.0	0.58	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799966		0.327	0.3266	0.2426	0.2982	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	6555.56	T=1198, C=801		T=668/530, C=417/384	1	
chr17:41234470	A/G	A	SNV		BRCA1	exonic	1								43.91	p.(=)		1929	A=0.5609, G=0.4391		Present				-	12	NM_007300.3	c.4308T>C	synonymous	0.13				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1060915		0.304 (ref)	0.326	0.1888	0.2796	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	7318.6	A=1082, G=847		A=540/542, G=418/429	2	
chr17:41244000	T/C	T	SNV		BRCA1	exonic	1								42.67	p.Lys1183Arg		1999	T=0.5733, C=0.4267		Present				-	10	NM_007300.3	c.3548A>G	missense	-0.44	1.0	26.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16942,rs80357956		0.324 (ref)	0.3244	0.2383	0.2952	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	7271.93	T=1146, C=853		T=582/564, C=384/469	3	
chr17:41244435	T/C	T	SNV		BRCA1	exonic	1								42.90	p.Glu1038Gly		2000	T=0.571, C=0.429		Present				-	10	NM_007300.3	c.3113A>G	missense	0.11	0.02	98.0	0.158	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16941,rs80357920		0.303 (ref)	0.3255	0.1884	0.279	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	7336.94	T=1142, C=858		T=525/617, C=413/445	2	
chr17:41244936	G/A	G	SNV		BRCA1	exonic	1								43.09	p.Pro871Leu		1996	G=0.5691, A=0.4309		Present				-	10	NM_007300.3	c.2612C>T	missense	0.94	1.0	98.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs799917,rs80357962		0.483	0.3359	0.2	0.4932	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	7375.59	G=1136, A=860		G=592/544, A=447/413	2	
chr17:41245237	A/G	A	SNV		BRCA1	exonic	1								40.84	p.(=)		1648	A=0.5916, G=0.4084		Present				-	10	NM_007300.3	c.2311T>C	synonymous	-0.83				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16940		0.302 (ref)	0.3237	0.1877	0.2776	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	5552.81	A=975, G=673		A=493/482, G=347/326	2	
chr17:41245466	G/A	G	SNV		BRCA1	exonic	1								38.50	p.(=)		2000	G=0.615, A=0.385		Present				-	10	NM_007300.3	c.2082C>T	synonymous	-0.08				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799949		0.324 (ref)	0.3244	0.2396	0.2957	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	6149.36	G=1230, A=770		G=662/568, A=412/358	1	
chr17:56435885	T/T	G	SNV		RNF43	exonic	1								100.00	p.Leu418Met		1406	G=0.0, T=1.0		Present				-	9	NM_017763.4	c.1252C>A	missense	2.18	0.0	15.0	0.948	Zinc finger	rs2526374		0.398 (ref)	0.3591	0.4024	0.3738	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	21283.1	G=0, T=1406		G=0/0, T=711/695	1	
chr17:56492800	T/C	T	SNV		RNF43	exonic	1								58.73	p.Ile47Val		1999	T=0.4127, C=0.5873		Present				-	2	NM_017763.4	c.139A>G	missense	0.97	0.1	29.0	0.001	Zinc finger	rs3744093		0.392 (ref)	0.3851	0.2174	0.3283	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	12169.7	T=825, C=1174		T=397/428, C=575/599	1	
chr19:15271771	A/A	G	SNV		NOTCH3	exonic	1								100.00	p.Ala2223Val		1487	G=0.0, A=1.0		Present				-	33	NM_000435.2	c.6668C>T	missense	0.08	0.18	64.0	0.001	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044009		0.368 (ref)	0.1987	0.397	0.2651	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	22491.5	G=0, A=1487		G=0/0, A=708/779	1	
chr19:15278057	G/G	A	SNV		NOTCH3	splicesite_3	1								100.00			955	A=0.0, G=1.0		Present				-	29	NM_000435.2			0.62				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1548555		0.133 (ref)	0.1034	0.0236	0.0763	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	14550.7	A=0, G=955		A=0/0, G=451/504	2	
chr19:15285052	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		1233	T=0.0, C=1.0		Present				-	25	NM_000435.2	c.4563A>G	synonymous	-1.43				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044006		0.133 (ref)	0.1002	0.0223	0.0739	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	18736.4	T=0, C=1233		T=0/0, C=625/608	1	
chr19:15292437	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		764	T=0.0, C=1.0		Present				-	17	NM_000435.2	c.2742A>G	synonymous	-4.38				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043997		0.233 (ref)	0.1299	0.3636	0.2095	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	11454.4	T=0, C=764		T=0/0, C=424/340	1	
chr19:15295134	A/A	G	SNV		NOTCH3	exonic	1								100.00	p.(=)		1232	G=0.0, A=1.0		Present				-	16	NM_000435.2	c.2538C>T	synonymous	-0.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043996		0.462 (ref)	0.2849	0.2762	0.4336	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	18698.9	G=0, A=1232		G=0/0, A=630/602	1	
chr19:15298136	C/A	C	SNV		NOTCH3	exonic	1								62.42	p.(=)		628	C=0.3758, A=0.6242		Present				-	11	NM_000435.2	c.1620G>T	synonymous	-2.64				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs75617410		0.01 (ref)	2.0E-4	0.0	2.0E-4		Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	4204.63	C=236, A=392		C=133/103, A=221/171	1	
chr19:15302844	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		1734	T=0.0, C=1.0		Present				-	4	NM_000435.2	c.606A>G	synonymous	-2.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043994		0.144 (ref)	0.1224	0.0878	0.1107	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	26189.6	T=0, C=1734		T=0/0, C=820/914	1	
chr19:30314666	C/T	C	SNV		CCNE1	exonic	1								39.88	p.(=)		1364	C=0.6012, T=0.3988		Present				+	12	NM_001238.2	c.1215C>T	synonymous	-1.18				Cyclin	rs7257694		0.216 (ref)	0.3899	0.111	0.2954	YES	DNA-dependent DNA replication initiation,G1/S transition of mitotic cell cycle,Wnt receptor signaling pathway,androgen receptor binding,androgen receptor signaling pathway,antral ovarian follicle growth,cell division,cellular response to nutrient,centrosome,cyclin-dependent protein kinase holoenzyme complex,cyclin-dependent protein kinase regulator activity,cytoplasm,cytosol,kinase activity,liver development,mitotic cell cycle,nucleolus,nucleoplasm,nucleus,organ regeneration,positive regulation of cell differentiation,positive regulation of transcription, DNA-dependent,protein binding,protein kinase binding,protein phosphorylation,regulation of cyclin-dependent protein kinase activity,regulation of transcription involved in G1/S phase of mitotic cell cycle,response to corticosterone stimulus,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to ethanol,response to methylmercury,response to organic nitrogen,response to progesterone stimulus,response to purine-containing compound,response to vitamin E,transcription coactivator activity			0.00001	4413.7	C=820, T=544		C=447/373, T=319/225	1	
chr20:36030939	C/C	G	SNV		SRC	exonic	1								100.00	p.(=)		1101	G=0.0, C=1.0		Present				+	12	NM_198291.2	c.1218G>C	synonymous	-2.02				Protein kinase domain,Protein tyrosine kinase,SH2 domain,SH3 domain,Variant SH3 domain	rs1885257		0.012 (ref)					ATP binding,Ras protein signal transduction,SH2 domain binding,SH3/SH2 adaptor activity,T cell costimulation,axon guidance,blood coagulation,bone resorption,branching involved in mammary gland duct morphogenesis,caveola,cell adhesion,cell cycle,cell junction assembly,cellular membrane organization,cytoplasm,cytoskeleton,cytosol,ephrin receptor binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,forebrain development,heme binding,integrin binding,interspecies interaction between organisms,intracellular protein kinase cascade,ion channel binding,kinase activity,leukocyte migration,mitochondrial inner membrane,mitochondrion,nerve growth factor receptor signaling pathway,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,oogenesis,peptidyl-tyrosine phosphorylation,phosphorylation,plasma membrane,platelet activation,positive regulation of integrin activation,protein binding,protein kinase activity,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of bone resorption,regulation of intracellular estrogen receptor signaling pathway,regulation of vascular permeability,response to interleukin-1,signal complex assembly,signal transduction,uterus development	(2E)-N-{4-(3-bromophenyl)aminoquinazolin-6-yl}-4-(dimethylamino)but-2-enamide,1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo3,4-dpyrimidin-4-amine,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-naphthalen-1-ylurea,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-phenylurea,1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo3,4-dpyrimidin-4-amine,1-cyclopentyl-3-(1H-pyrrolo2,3-bpyridin-5-yl)-1H-pyrazolo3,4-dpyrimidin-4-amine,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,3-4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-3-YLPHENOL,4-(4-METHYL-1-PIPERAZINYL)METHYL-N-3-4-(3-PYRIDINYL)-2-PYRIMIDINYLAMINOPHENYL-BENZAMIDE,4-({4-(5-cyclopropyl-1H-pyrazol-3-yl)aminoquinazolin-2-yl}amino)phenylacetonitrile,Citric Acid,DPI59,Dasatinib,ISO24,Malonic acid,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,N6-Benzyl Adenosine-5'-Diphosphate,Oxalic Acid,PAS219,PASBN,Phenylphosphate,Phosphonotyrosine,Purvalanol A,RU78191,RU78262,RU78299,RU78300,RU78783,RU79072,RU79073,RU79256,RU81843,RU82129,RU82197,RU82209,RU83876,RU84687,RU85053,RU85493,RU90395		0.00001	16664.3	G=0, C=1101		G=0/0, C=553/548	2	
